$ADVM Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Adverum Biotechnologies, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Adverum Biotechnologies, Inc.. Get notifications about new insider transactions in Adverum Biotechnologies, Inc. for free.

Page: < prev 1 2 3 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 18 2018	ADVM	Adverum Biotechnol ...	PATTERSON LEONE D	SVP, CFO, Interim P ...	Grant	A	0.00	88,496	0	268,496	180 K to 268.5 K (+49.16 %)
Jun 15 2018	ADVM	Adverum Biotechnol ...	Machado Patrick	Director	Option Exercise	A	6.25	35,000	218,750	35,000
Jun 15 2018	ADVM	Adverum Biotechnol ...	Spivey Richard N.	Director	Option Exercise	A	6.25	35,000	218,750	35,000
Jun 15 2018	ADVM	Adverum Biotechnol ...	Carter Eric G	Director	Option Exercise	A	6.25	35,000	218,750	35,000
Jun 15 2018	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Option Exercise	A	6.25	35,000	218,750	35,000
Jun 15 2018	ADVM	Adverum Biotechnol ...	Finer Mitchell H.	Director	Option Exercise	A	6.25	35,000	218,750	35,000
Jun 15 2018	ADVM	Adverum Biotechnol ...	Cleveland Paul B	Director	Option Exercise	A	6.25	35,000	218,750	35,000
Feb 20 2018	ADVM	Adverum Biotechnol ...	Machado Patrick	Director	Option Exercise	A	6.40	10,000	64,000	10,000
Feb 20 2018	ADVM	Adverum Biotechnol ...	Cheng Jennifer C.	General Counsel	Option Exercise	A	6.40	114,000	729,600	114,000
Feb 20 2018	ADVM	Adverum Biotechnol ...	PATTERSON LEONE D	Chief Financial Off ...	Option Exercise	A	6.40	160,000	1,024,000	160,000
Feb 20 2018	ADVM	Adverum Biotechnol ...	Gasmi Mehdi	Chief Science & Tec ...	Option Exercise	A	6.40	160,000	1,024,000	160,000
Feb 20 2018	ADVM	Adverum Biotechnol ...	Countouriotis Athena	SVP, Chief Medical ...	Option Exercise	A	6.40	160,000	1,024,000	160,000
Feb 20 2018	ADVM	Adverum Biotechnol ...	Salzman Amber	President and CEO	Option Exercise	A	6.40	478,000	3,059,200	478,000
Sep 08 2017	ADVM	Adverum Biotechnol ...	Carter Eric G	Director	Option Exercise	A	2.70	69,000	186,300	69,000
Sep 08 2017	ADVM	Adverum Biotechnol ...	Carter Eric G	Director	Grant	A	0.00	48,000	0	48,000	0 to 48 K
Jun 21 2017	ADVM	Adverum Biotechnol ...	Countouriotis Athena	SVP, Chief Medical ...	Option Exercise	A	2.90	213,000	617,700	213,000
Jun 21 2017	ADVM	Adverum Biotechnol ...	Countouriotis Athena	SVP, Chief Medical ...	Grant	A	0.00	150,000	0	150,000	0 to 150 K
Jun 14 2017	ADVM	Adverum Biotechnol ...	Finer Mitchell H.	Director	Option Exercise	A	2.75	33,602	92,406	33,602
Jun 14 2017	ADVM	Adverum Biotechnol ...	Finer Mitchell H.	Director	Grant	A	0.00	22,727	0	603,069	580.3 K to 603.1 K (+3.92 %)
Jun 14 2017	ADVM	Adverum Biotechnol ...	Spivey Richard N.	Director	Option Exercise	A	2.75	33,602	92,406	33,602
Jun 14 2017	ADVM	Adverum Biotechnol ...	Spivey Richard N.	Director	Grant	A	0.00	22,727	0	70,804	48.1 K to 70.8 K (+47.27 %)
Jun 14 2017	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Option Exercise	A	2.75	33,602	92,406	33,602
Jun 14 2017	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	22,727	0	70,380	47.7 K to 70.4 K (+47.69 %)
Jun 14 2017	ADVM	Adverum Biotechnol ...	Cleveland Paul B	Chief Executive Off ...	Option Exercise	A	2.75	33,602	92,406	33,602
Jun 14 2017	ADVM	Adverum Biotechnol ...	Cleveland Paul B	Chief Executive Off ...	Grant	A	0.00	22,727	0	22,727	0 to 22.7 K
Jun 14 2017	ADVM	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Option Exercise	A	2.75	33,602	92,406	33,602
Jun 14 2017	ADVM	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Grant	A	0.00	22,727	0	398,991	376.3 K to 399 K (+6.04 %)
Jun 14 2017	ADVM	Adverum Biotechnol ...	Machado Patrick	Director	Option Exercise	A	2.75	33,602	92,406	33,602
Jun 14 2017	ADVM	Adverum Biotechnol ...	Machado Patrick	Director	Grant	A	0.00	22,727	0	68,182	45.5 K to 68.2 K (+50.00 %)
May 01 2017	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	2,223	0	47,653	45.4 K to 47.7 K (+4.89 %)
Apr 21 2017	ADVM	Adverum Biotechnol ...	Spivey Richard N.	Director	Option Exercise	A	2.60	69,061	179,559	69,061
Apr 21 2017	ADVM	Adverum Biotechnol ...	Spivey Richard N.	Director	Grant	A	0.00	48,077	0	48,077	0 to 48.1 K
Apr 03 2017	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,704	0	45,430	41.7 K to 45.4 K (+8.88 %)
Mar 16 2017	ADVM	Adverum Biotechnol ...	Machado Patrick	Director	Option Exercise	A	2.75	64,767	178,109	64,767
Mar 16 2017	ADVM	Adverum Biotechnol ...	Machado Patrick	Director	Grant	A	0.00	45,455	0	45,455	0 to 45.5 K
Mar 02 2017	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,774	0	41,726	38 K to 41.7 K (+9.94 %)
Feb 13 2017	AAVL	Adverum Biotechnol ...	Salzman Amber	President and CEO	Option Exercise	A	2.70	378,000	1,020,600	378,000
Feb 13 2017	AAVL	Adverum Biotechnol ...	Salzman Amber	President and CEO	Grant	A	0.00	262,000	0	891,766	629.8 K to 891.8 K (+41.60 %)
Feb 13 2017	AAVL	Adverum Biotechnol ...	PATTERSON LEONE D	CFO	Option Exercise	A	2.70	116,000	313,200	116,000
Feb 13 2017	AAVL	Adverum Biotechnol ...	PATTERSON LEONE D	CFO	Grant	A	0.00	80,000	0	180,000	100 K to 180 K (+80.00 %)
Feb 13 2017	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	Chief Science & Tec ...	Option Exercise	A	2.70	181,000	488,700	181,000
Feb 13 2017	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	Chief Science & Tec ...	Grant	A	0.00	125,000	0	289,535	164.5 K to 289.5 K (+75.97 %)
Feb 13 2017	AAVL	Adverum Biotechnol ...	Barone Samuel B.	SVP, Clinical Devel ...	Option Exercise	A	2.70	84,000	226,800	84,000
Feb 13 2017	AAVL	Adverum Biotechnol ...	Barone Samuel B.	SVP, Clinical Devel ...	Grant	A	0.00	58,000	0	172,335	114.3 K to 172.3 K (+50.73 %)
Feb 02 2017	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,449	0	37,952	34.5 K to 38 K (+10.00 %)
Jan 03 2017	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,449	0	34,503	31.1 K to 34.5 K (+11.11 %)
Dec 01 2016	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,509	0	31,054	27.5 K to 31.1 K (+12.74 %)
Nov 01 2016	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,390	0	27,545	24.2 K to 27.5 K (+14.03 %)
Jul 01 2016	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Option Exercise	A	4.14	44,248	183,187	44,248
Jul 01 2016	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	24,155	0	24,155	0 to 24.2 K
Jul 01 2016	AAVL	Adverum Biotechnol ...	Finer Mitchell H.	Director	Option Exercise	A	4.14	44,248	183,187	44,248
Jul 01 2016	AAVL	Adverum Biotechnol ...	Finer Mitchell H.	Director	Grant	A	0.00	24,155	0	580,342	556.2 K to 580.3 K (+4.34 %)
Jun 21 2016	AAVL	Adverum Biotechnol ...	Barone Samuel B.	SVP, Clinical Devel ...	Option Exercise	A	3.31	50,000	165,500	50,000
Jun 21 2016	AAVL	Adverum Biotechnol ...	Barone Samuel B.	SVP, Clinical Devel ...	Grant	A	0.00	20,000	0	114,335	94.3 K to 114.3 K (+21.20 %)
Jun 16 2016	AAVL	Adverum Biotechnol ...	PATTERSON LEONE D	CFO	Option Exercise	A	3.44	200,000	688,000	200,000
Jun 16 2016	AAVL	Adverum Biotechnol ...	PATTERSON LEONE D	CFO	Grant	A	0.00	100,000	0	100,000	0 to 100 K
May 13 2016	AAVL	Adverum Biotechnol ...	Salzman Amber	President and COO	Option Exercise	A	4.14	218,000	902,520	218,000
May 13 2016	AAVL	Adverum Biotechnol ...	Salzman Amber	President and COO	Option Exercise	A	0.21	377,890	79,357	377,890
May 13 2016	AAVL	Adverum Biotechnol ...	Salzman Amber	President and COO	Grant	A	0.00	629,766	0	629,766	0 to 629.8 K
May 13 2016	AAVL	Adverum Biotechnol ...	Russo Carlo	EVP and Chief Medic ...	Option Exercise	A	4.14	66,000	273,240	66,000
May 13 2016	AAVL	Adverum Biotechnol ...	Russo Carlo	EVP and Chief Medic ...	Option Exercise	A	0.21	715,991	150,358	715,991
May 13 2016	AAVL	Adverum Biotechnol ...	Cleveland Paul B	Chief Executive Off ...	Option Exercise	A	4.14	381,000	1,577,340	381,000
Mar 02 2016	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	3,907	0	31,951	28 K to 32 K (+13.93 %)
Feb 17 2016	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Option Exercise	A	4.80	11,905	57,144	11,905
Feb 17 2016	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Grant	A	0.00	8,333	0	10,333	2 K to 10.3 K (+416.65 %)
Feb 17 2016	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Option Exercise	A	4.80	11,905	57,144	11,905
Feb 17 2016	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Grant	A	0.00	8,333	0	376,264	367.9 K to 376.3 K (+2.26 %)
Feb 17 2016	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	A	4.80	11,905	57,144	11,905
Feb 17 2016	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Grant	A	0.00	8,333	0	531,322	523 K to 531.3 K (+1.59 %)
Feb 17 2016	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Option Exercise	A	4.80	11,905	57,144	11,905
Feb 17 2016	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	8,333	0	28,044	19.7 K to 28 K (+42.28 %)
Feb 17 2016	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	Chief Scientific Of ...	Option Exercise	A	4.80	188,000	902,400	188,000
Feb 17 2016	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	Chief Scientific Of ...	Grant	A	0.00	125,000	0	161,803	36.8 K to 161.8 K (+339.65 %)
Feb 17 2016	AAVL	Adverum Biotechnol ...	Rubio Roman G.	SVP, Translational ...	Option Exercise	A	4.80	75,000	360,000	75,000
Feb 17 2016	AAVL	Adverum Biotechnol ...	Rubio Roman G.	SVP, Translational ...	Grant	A	0.00	50,000	0	165,650	115.7 K to 165.7 K (+43.23 %)
Feb 17 2016	AAVL	Adverum Biotechnol ...	Barone Samuel B.	Chief Medical Offic ...	Option Exercise	A	4.80	75,000	360,000	75,000
Feb 17 2016	AAVL	Adverum Biotechnol ...	Barone Samuel B.	Chief Medical Offic ...	Grant	A	0.00	50,000	0	91,603	41.6 K to 91.6 K (+120.18 %)
Feb 17 2016	AAVL	Adverum Biotechnol ...	Swartzburg Michael	Principal Accountin ...	Grant	A	0.00	36,900	0	82,113	45.2 K to 82.1 K (+81.61 %)
Feb 17 2016	AAVL	Adverum Biotechnol ...	Braun Shirley	VP, Human Resources	Grant	A	0.00	116,900	0	161,140	44.2 K to 161.1 K (+264.24 %)
Feb 01 2016	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	3,334	0	19,711	16.4 K to 19.7 K (+20.36 %)
Jan 04 2016	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	2,101	0	16,377	14.3 K to 16.4 K (+14.72 %)
Dec 11 2015	AAVL	Adverum Biotechnol ...	Cleveland Paul B	President and CEO	Option Exercise	A	9.04	910,000	8,226,400	910,000
Dec 02 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	1,909	0	14,276	12.4 K to 14.3 K (+15.44 %)
Nov 02 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	2,373	0	12,367	10 K to 12.4 K (+23.74 %)
Oct 02 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	2,428	0	9,994	7.6 K to 10 K (+32.09 %)
Sep 23 2015	AAVL	Adverum Biotechnol ...	Braun Shirley	VP, Human Resources	Grant	A	0.00	3,500	0	44,240	40.7 K to 44.2 K (+8.59 %)
Sep 11 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	5,566	0	7,566	2 K to 7.6 K (+278.30 %)
Aug 25 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	Chief Scientific Of ...	Grant	A	0.00	29,160	0	36,160	7 K to 36.2 K (+416.57 %)
Aug 25 2015	AAVL	Adverum Biotechnol ...	Barone Samuel B.	Chief Medical Offic ...	Grant	A	0.00	33,960	0	40,960	7 K to 41 K (+485.14 %)
Aug 25 2015	AAVL	Adverum Biotechnol ...	Rubio Roman G.	SVP, Translational ...	Grant	A	0.00	108,650	0	115,650	7 K to 115.7 K (+1,552.14 %)
Aug 25 2015	AAVL	Adverum Biotechnol ...	Hull Hans	Chief Executive Off ...	Grant	A	0.00	117,590	0	137,210	19.6 K to 137.2 K (+599.34 %)
Aug 25 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Grant	A	0.00	32,930	0	41,930	9 K to 41.9 K (+365.89 %)
Jun 17 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	SVP,Pharmaceutical ...	Option Exercise	M	2.75	500	1,375	95,000
Jun 17 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	SVP,Pharmaceutical ...	Sell	S	39.86	500	19,931	7,000	7.5 K to 7 K (-6.67 %)
Jun 17 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	SVP,Pharmaceutical ...	Buy	M	2.75	500	1,375	7,500	7 K to 7.5 K (+7.14 %)
Jun 17 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	39.86	1,192	47,516	37,161	38.4 K to 37.2 K (-3.11 %)
Jun 17 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	39.86	16,875	672,671	367,931	384.8 K to 367.9 K (-4.39 %)
Jun 16 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Option Exercise	M	0.19	8,300	1,577	12,200
Jun 16 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Buy	M	0.19	8,300	1,577	19,620	11.3 K to 19.6 K (+73.32 %)
Jun 15 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.97	1,900	75,939	522,989	524.9 K to 523 K (-0.36 %)
Jun 15 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Option Exercise	M	3.15	3,500	11,025	233,000
Jun 15 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Sell	S	39.94	3,500	139,795	9,000	12.5 K to 9 K (-28.00 %)
Jun 15 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Buy	M	3.15	3,500	11,025	12,500	9 K to 12.5 K (+38.89 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	GUERIN JOHN PATRICK ET AL	Director	Sell	S	206.00	699	143,994	150,000	150.7 K to 150 K (-0.46 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	GUERIN JOHN PATRICK ET AL	Director	Sell	S	208.00	1	208	150,699	150.7 K to 150.7 K (0.00 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	GUERIN JOHN PATRICK ET AL	Director	Sell	S	206.00	1,205	248,230	150,700	151.9 K to 150.7 K (-0.79 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.91	600	23,948	524,889	525.5 K to 524.9 K (-0.11 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	37.35	200	7,470	525,489	525.7 K to 525.5 K (-0.04 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	36.20	7,000	253,402	525,689	532.7 K to 525.7 K (-1.31 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	35.52	15,300	543,456	532,689	548 K to 532.7 K (-2.79 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Sell	S	38.90	6,995	272,123	258,988	266 K to 259 K (-2.63 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Sell	S	38.04	12,970	493,339	265,983	279 K to 266 K (-4.65 %)
Jun 11 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Sell	S	36.89	5,035	185,733	278,953	284 K to 279 K (-1.77 %)
Jun 10 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	39.88	176	7,019	38,353	38.5 K to 38.4 K (-0.46 %)
Jun 10 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	38.96	475	18,505	38,529	39 K to 38.5 K (-1.22 %)
Jun 10 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	37.96	541	20,537	39,004	39.5 K to 39 K (-1.37 %)
Jun 10 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	500	1,375	95,500
Jun 10 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	39.88	82	3,270	7,000	7.1 K to 7 K (-1.16 %)
Jun 10 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	38.95	183	7,128	7,082	7.3 K to 7.1 K (-2.52 %)
Jun 10 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	37.97	235	8,923	7,265	7.5 K to 7.3 K (-3.13 %)
Jun 10 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	500	1,375	7,500	7 K to 7.5 K (+7.14 %)
Jun 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	40.08	5,000	200,414	547,989	553 K to 548 K (-0.90 %)
Jun 05 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Option Exercise	M	0.19	2,000	380	20,500
Jun 05 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Sell	S	37.64	2,000	75,283	11,320	13.3 K to 11.3 K (-15.02 %)
Jun 05 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Buy	M	0.19	2,000	380	13,320	11.3 K to 13.3 K (+17.67 %)
Jun 02 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	36.81	210	7,730	39,545	39.8 K to 39.5 K (-0.53 %)
Jun 02 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	36.11	982	35,461	39,755	40.7 K to 39.8 K (-2.41 %)
Jun 02 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	36.81	3,093	113,854	384,806	387.9 K to 384.8 K (-0.80 %)
Jun 02 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	36.11	14,157	511,189	387,899	402.1 K to 387.9 K (-3.52 %)
May 29 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	500	1,375	96,000
May 29 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	38.02	500	19,009	7,000	7.5 K to 7 K (-6.67 %)
May 29 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	500	1,375	7,500	7 K to 7.5 K (+7.14 %)
May 27 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	38.30	102	3,906	40,737	40.8 K to 40.7 K (-0.25 %)
May 27 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	37.59	304	11,428	40,839	41.1 K to 40.8 K (-0.74 %)
May 27 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	36.52	786	28,703	41,143	41.9 K to 41.1 K (-1.87 %)
May 22 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	38.88	5,196	202,043	402,056	407.3 K to 402.1 K (-1.28 %)
May 22 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	38.16	11,679	445,644	407,252	418.9 K to 407.3 K (-2.79 %)
May 22 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	500	1,375	96,500
May 22 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	38.87	500	19,435	7,000	7.5 K to 7 K (-6.67 %)
May 22 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	500	1,375	7,500	7 K to 7.5 K (+7.14 %)
May 21 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	36.91	1,000	36,911	10,531	11.5 K to 10.5 K (-8.67 %)
May 21 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	36.91	1,000	36,911	10,531	11.5 K to 10.5 K (-8.67 %)
May 21 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	36.91	1,000	36,911	10,531	11.5 K to 10.5 K (-8.67 %)
May 19 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	35.31	1,192	42,086	41,929	43.1 K to 41.9 K (-2.76 %)
May 18 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	36.00	4,525	162,886	552,989	557.5 K to 553 K (-0.81 %)
May 18 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	35.36	17,975	635,666	557,514	575.5 K to 557.5 K (-3.12 %)
May 15 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	500	1,375	97,000
May 15 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	35.31	500	17,656	7,000	7.5 K to 7 K (-6.67 %)
May 15 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	500	1,375	7,500	7 K to 7.5 K (+7.14 %)
May 13 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	34.94	715	24,984	575,489	576.2 K to 575.5 K (-0.12 %)

Page: < prev 1 2 3 4 next >